article thumbnail

New Eli Lilly Eczema Drug Brings Competition and Dosing Edge Versus Sanofi, LEO Pharma Meds

MedCity News

billion acquisition of Dermira in 2020. The post New Eli Lilly Eczema Drug Brings Competition and Dosing Edge Versus Sanofi, LEO Pharma Meds appeared first on MedCity News. Eli Lilly drug Ebglyss is now FDA-approved for atopic dermatitis, an inflammatory skin disorder also known as eczema. The biologic drug came from Lilly’s $1.1

article thumbnail

Pharma is big business whose goal is to maximize shareholder value

World of DTC Marketing

From 2016 to 2020, the 14 leading drug companies spent $577 billion on stock buybacks and dividends—$56 billion more than they spent on R&D over the same period.” ” From 2016 to 2020, compensation for the 14 companies’ top executives totaled $3.2 The drug industry is driven by profits, not by patient’s needs.

Pharma 292
article thumbnail

The Top 10 Medical Device Success Podcasts in 2020!

Medical Device Success

35 podcasts were produced in our inaugural year of 2020. 1 Ep 4 – The Future of the Medical Device Industry in the Covid-19 Era, April 12, 2020. 2 Ep 6 – Selling in a Covid-19 Word – New Sales Practices, April 26, 2020. 3 Ep 10 – The Reopening, Covid-19 and what it means for Medical Devices, May 24, 2020.

Medical 100
article thumbnail

Innovation key for boosting UK biopharma competitiveness

European Pharmaceutical Review

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. The ‘Sectoral Systems of Innovation and the UK’s Competitiveness’ reports assess the value-added per capita of each sector and how they compare internationally.

article thumbnail

Competition is on the horizon for costly narcolepsy treatments

pharmaphorum

But increased competition is on the horizon. In 2020, and in an attempt to abate the drawback, Jazz got FDA approval for Xywav, which is a mixture of calcium, magnesium, and potassium salts that contains 92% less sodium than Xyrem. Competition starts to heat up. Classic treatment options. Xyrem is one of three that has a patent.

article thumbnail

Pharma’s reputational high will be short-lived

World of DTC Marketing

Pharma has gone to court again and again to delay generic competition of biologic drugs. One company AbbVie has used the courts to stop competition of its top drug Humira. By the look of 2020’s results, he’s on the right track—and his compensation shows it. For writing that 2020 success story, CEO Albert Bourla, Ph.D.,

Pharma 186
article thumbnail

2020 Sales Hiring Forecast

Sales Talent

By comparing these forecasts to historical data, we developed our 2020 sales hiring forecast. 2020 Sales Hiring Forecast. Sales hiring in 2020 shows no signs of slowing down. Manpower forecasts a Q1 2020 Net Employment Outlook for the U.S. 4 percent in 2020. 2019 Sales Hiring in Review. YOY increase.

Sales 52